176 related articles for article (PubMed ID: 12513058)
1. Contamination of the blood supply in the 1980s and 1990s.
Pozen A
Ann Intern Med; 2003 Jan; 138(1):78-9. PubMed ID: 12513058
[No Abstract] [Full Text] [Related]
2. Danish court clears drug firm of blood contamination.
Dolley M
BMJ; 1995 Mar; 310(6979):552. PubMed ID: 7888925
[No Abstract] [Full Text] [Related]
3. Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s.
Weinberg PD; Hounshell J; Sherman LA; Godwin J; Ali S; Tomori C; Bennett CL
Ann Intern Med; 2002 Feb; 136(4):312-9. PubMed ID: 11848729
[TBL] [Abstract][Full Text] [Related]
4. Legal aspects of transfusion medicine.
Sazama K
MLO Med Lab Obs; 1994 Nov; 26(11):33-7, 40. PubMed ID: 10138502
[No Abstract] [Full Text] [Related]
5. Compensation vote sends message to US haemophiliacs with HIV.
Rovner J
Lancet; 1998 May; 351(9116):1640. PubMed ID: 9620730
[No Abstract] [Full Text] [Related]
6. "For any shortcomings on the part of the Red Cross, we are deeply sorry".
Davey M; Perrault R
CMAJ; 1997 Aug; 157(3):245-6. PubMed ID: 9269188
[No Abstract] [Full Text] [Related]
7. "For any shortcomings on the part of the Red Cross, we are deeply sorry".
Normand A
CMAJ; 1997 Aug; 157(3):245; author reply 246. PubMed ID: 9269187
[No Abstract] [Full Text] [Related]
8. Medicine betrayed: hemophilia patients and HIV in the US.
Keshavjee S; Weiser S; Kleinman A
Soc Sci Med; 2001 Oct; 53(8):1081-94. PubMed ID: 11556777
[TBL] [Abstract][Full Text] [Related]
9. Within the walls of Parliament: government decision-making around compensation for contaminated blood.
Faulkner DB
Health Law Can; 2005 May; 25(4):53-72. PubMed ID: 16053052
[No Abstract] [Full Text] [Related]
10. Rethinking blood shield statutes in view of the hepatitis C pandemic and other emerging threats to the blood supply.
Rueda A
J Health Law; 2001; 34(3):419-58. PubMed ID: 11571894
[TBL] [Abstract][Full Text] [Related]
11. Blood ties: accountability for blood quality in New Zealand.
Howden-Chapman P
Health Policy; 1994 Jan; 27(1):35-51. PubMed ID: 10133135
[TBL] [Abstract][Full Text] [Related]
12. Revisiting Factor VIII cases: is it time for an agency adjudication system?
Su YC
Food Drug Law J; 2008; 63(4):943-61. PubMed ID: 19601390
[No Abstract] [Full Text] [Related]
13. Contaminated blood.
Machin SJ
Med Leg J; 2004; 72(Pt 3):77-87. PubMed ID: 15524115
[No Abstract] [Full Text] [Related]
14. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
Steinberg D
J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064
[No Abstract] [Full Text] [Related]
15. Lawsuits are set to obstruct Canada's blood inquiry.
Spurgeon D
BMJ; 1996 Feb; 312(7028):398. PubMed ID: 8601104
[No Abstract] [Full Text] [Related]
16. Surrogate testing was not required under blood shield law.
AIDS Policy Law; 1998 Feb; 13(3):2. PubMed ID: 11365104
[TBL] [Abstract][Full Text] [Related]
17. [Administration of an HIV contaminated blood unit and hospital liability].
Ehmke W; Bielefeld ; Haike HJ
Versicherungsmedizin; 1992 Jun; 44(3):76-80. PubMed ID: 1621325
[No Abstract] [Full Text] [Related]
18. Case consolidation approved in blood contamination suits.
AIDS Policy Law; 2004 May; 19(9):3. PubMed ID: 15202396
[No Abstract] [Full Text] [Related]
19. HIV-related information and the tension between confidentiality and liberal discovery. The need for a uniform approach.
Colella U
J Leg Med; 1995 Mar; 16(1):33-100. PubMed ID: 7738441
[No Abstract] [Full Text] [Related]
20. Time limit for product claims applied to contaminated blood.
AIDS Policy Law; 2001 Nov; 16(21):8. PubMed ID: 11769191
[No Abstract] [Full Text] [Related]
[Next] [New Search]
